Insider Transactions in Q1 2023 at Trevi Therapeutics, Inc. (TRVI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Lisa Delfini Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
892
-3.48%
|
$892
$1.75 P/Share
|
|
Mar 13
2023
|
Lisa Delfini Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,291
+8.21%
|
$0
$0.51 P/Share
|
|
Mar 07
2023
|
Farrell Simon Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+32.24%
|
$0
$0.51 P/Share
|
|
Feb 13
2023
|
Lisa Delfini Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,474
-26.64%
|
$16,948
$2.45 P/Share
|
|
Feb 13
2023
|
Lisa Delfini Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+46.37%
|
$0
$0.51 P/Share
|